Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration
- PMID: 25728086
- DOI: 10.1016/j.jcv.2015.01.013
Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration
Abstract
Background: The benefits of intravenous immunoglobulin (IVIG) therapy for severe neonatal enterovirus infections are still controversial.
Object: To evaluate whether timing of IVIG administration might affect clinical outcomes of neonates with severe enteroviral infections.
Study designs: We retrospectively analyzed 67 neonates with culture-confirmed severe enteroviral infection, defined as hepatitis with coagulopathy and thrombocytopenia. Clinical features, outcomes and the usage of IVIG therapy were collected and analyzed. IVIG administered within 3 days of illness onset was classified as early IVIG therapy.
Results: Of the 67 cases, 38 (57%) were male, 27 (40%) were premature, 57 (85%) had disease onset within 7 days of life and all but 2 cases were caused by coxsackievirus B group. Ten infants (15%) had clinically evident myocarditis. 41 infants (61%) received IVIG therapy and 29 were early IVIG therapy. Fifteen infants (22%) eventually died, without IVIG therapy for 7 infants. The deceased had a significantly higher peak serum aspartate aminotransferase (AST) level than the survivors (3539 vs. 866 IU/L, p<0.01). The timing of IVIG therapy was highly correlated with the timing of peak AST level in patients with early IVIG therapy. Multiple logistic regression analysis showed that a higher nadir hemoglobin level (adjusted odds ratio 2.8, 95% confidence interval: 1.4-5.4), no concurrent myocarditis (42.6 [3.4-5289]) and early IVIG therapy (14.7 [1.3-163]) were independently associated with a favorable prognosis.
Conclusions: In defined severe neonatal enterovirus infections, serum AST level correlated with the disease severity. Early IVIG therapy, if needed, may be beneficial for survival.
Keywords: Enterovirus; Hepatitis; Intravenous immunoglobulin; Myocarditis; Neonates.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
A case of myocarditis following neonatal meningitis caused by coxsackievirus B1 in spite of intravenous immunoglobulin treatment.J Trop Pediatr. 2014 Apr;60(2):164-7. doi: 10.1093/tropej/fmt086. Epub 2013 Oct 11. J Trop Pediatr. 2014. PMID: 24122863
-
Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections.Pediatr Infect Dis J. 2003 Oct;22(10):889-94. doi: 10.1097/01.inf.0000091294.63706.f3. Pediatr Infect Dis J. 2003. PMID: 14551490
-
Enteroviral infections in children with malignant disease: a 5-year study in a single institution.J Infect. 2007 Apr;54(4):387-92. doi: 10.1016/j.jinf.2006.07.002. Epub 2006 Sep 7. J Infect. 2007. PMID: 16959324
-
Enteroviral infection in neonates.J Microbiol Immunol Infect. 2019 Dec;52(6):851-857. doi: 10.1016/j.jmii.2019.08.018. Epub 2019 Sep 30. J Microbiol Immunol Infect. 2019. PMID: 31607572 Review.
-
Presentation, diagnosis, and management of enterovirus infections in neonates.Paediatr Drugs. 2004;6(1):1-10. doi: 10.2165/00148581-200406010-00001. Paediatr Drugs. 2004. PMID: 14969566 Review.
Cited by
-
Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis.Sci Rep. 2019 Jul 18;9(1):10459. doi: 10.1038/s41598-019-46888-0. Sci Rep. 2019. PMID: 31320679 Free PMC article.
-
Severe neonatal enterovirus infection in twins with different outcomes: A case report.Front Pediatr. 2023 Sep 6;11:1181698. doi: 10.3389/fped.2023.1181698. eCollection 2023. Front Pediatr. 2023. PMID: 37744436 Free PMC article.
-
Enteroviral Infections in Infants.Newborn (Clarksville). 2022 Jul-Sep;1(3):297-305. doi: 10.5005/jp-journals-11002-0036. Epub 2022 Jul 10. Newborn (Clarksville). 2022. PMID: 36304567 Free PMC article.
-
High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants.BMC Pediatr. 2018 Feb 21;18(1):74. doi: 10.1186/s12887-018-1055-5. BMC Pediatr. 2018. PMID: 29466960 Free PMC article.
-
Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023.Euro Surveill. 2023 Jun;28(22):2300253. doi: 10.2807/1560-7917.ES.2023.28.22.2300253. Euro Surveill. 2023. PMID: 37261730 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources